During the past decade, The First Hospital of Hebei Medical University conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 1 clinical trials were completed, i.e. on average, 2.6% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 1 clinical trials were completed. i.e. 4.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The First Hospital of Hebei Medical University" #1 sponsor was "Hebei Medical University" with 14 trials, followed by "First Hospital of Shijiazhuang City" with 4 trials sponsored, "ZhuHai Cardionovum Medical Device Co., Ltd." with 3 trials sponsored, "Bayer" with 2 trials sponsored and "Boehringer Ingelheim" with 2 trials sponsored. Other sponsors include 32 different institutions and companies that sponsored additional 37 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The First Hospital of Hebei Medical University" #1 collaborator was "Beijing Tiantan Hospital" with 3 trials as a collaborator, "Shanghai Changzheng Hospital" with 3 trials as a collaborator, "Tianjin Medical University General Hospital" with 3 trials as a collaborator, "Affiliated Hospital of North Sichuan Medical College" with 2 trials as a collaborator and "Anshan Central Hospital" with 2 trials as a collaborator. Other collaborators include 137 different institutions and companies that were collaborators in the rest 85 trials.

According to Clinical.Site data, the most researched conditions in "The First Hospital of Hebei Medical University" are "Heart Failure" (5 trials), "Carcinoma" (3 trials), "Heart Failure, Congestive" (3 trials), "Lung Neoplasm" (3 trials) and "Acute Ischemic Stroke" (2 trials). Many other conditions were trialed in "The First Hospital of Hebei Medical University" in a lesser frequency.

Most popular intervention types in "The First Hospital of Hebei Medical University" are "Drug" (37 trials), "Biological" (10 trials), "Device" (10 trials), "Other" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "mesenchymal stem cells" (4 trials), "Paclitaxel Releasing Peripheral Balloon Dilatation Catheter" (3 trials), "prednisone" (3 trials) and "Anlotinib Hydrochloride" (2 trials). Other intervention names were less common.

The vast majority of trials in "The First Hospital of Hebei Medical University" are 61 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "The First Hospital of Hebei Medical University". 3 are not yet recruiting, 13 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in The First Hospital of Hebei Medical University, 2 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in The First Hospital of Hebei Medical University, 11 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 11 trials that are defined as “Not Applicable".